全文获取类型
收费全文 | 4259篇 |
免费 | 236篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 129篇 |
妇产科学 | 100篇 |
基础医学 | 748篇 |
口腔科学 | 169篇 |
临床医学 | 422篇 |
内科学 | 673篇 |
皮肤病学 | 141篇 |
神经病学 | 398篇 |
特种医学 | 389篇 |
外科学 | 590篇 |
综合类 | 49篇 |
一般理论 | 1篇 |
预防医学 | 189篇 |
眼科学 | 94篇 |
药学 | 207篇 |
中国医学 | 8篇 |
肿瘤学 | 242篇 |
出版年
2022年 | 23篇 |
2021年 | 49篇 |
2020年 | 38篇 |
2019年 | 40篇 |
2018年 | 73篇 |
2017年 | 53篇 |
2016年 | 65篇 |
2015年 | 100篇 |
2014年 | 109篇 |
2013年 | 111篇 |
2012年 | 183篇 |
2011年 | 198篇 |
2010年 | 150篇 |
2009年 | 173篇 |
2008年 | 174篇 |
2007年 | 195篇 |
2006年 | 173篇 |
2005年 | 145篇 |
2004年 | 163篇 |
2003年 | 124篇 |
2002年 | 119篇 |
2001年 | 102篇 |
2000年 | 134篇 |
1999年 | 113篇 |
1998年 | 105篇 |
1997年 | 95篇 |
1996年 | 83篇 |
1995年 | 73篇 |
1994年 | 60篇 |
1993年 | 65篇 |
1992年 | 74篇 |
1991年 | 54篇 |
1990年 | 77篇 |
1989年 | 87篇 |
1988年 | 75篇 |
1987年 | 54篇 |
1986年 | 44篇 |
1985年 | 66篇 |
1984年 | 44篇 |
1983年 | 22篇 |
1982年 | 24篇 |
1980年 | 26篇 |
1979年 | 30篇 |
1978年 | 25篇 |
1977年 | 36篇 |
1976年 | 26篇 |
1975年 | 28篇 |
1974年 | 26篇 |
1971年 | 26篇 |
1880年 | 32篇 |
排序方式: 共有4575条查询结果,搜索用时 15 毫秒
991.
Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis 下载免费PDF全文
Lopamudra Das Roy Latha B Pathangey Teresa L Tinder Jorge L Schettini Helen E Gruber Pinku Mukherjee 《Breast cancer research : BCR》2009,11(4):R56-15
Introduction
Sites of chronic inflammation are often associated with the establishment and growth of various malignancies including breast cancer. A common inflammatory condition in humans is autoimmune arthritis (AA) that causes inflammation and deformity of the joints. Other systemic effects associated with arthritis include increased cellular infiltration and inflammation of the lungs. Several studies have reported statistically significant risk ratios between AA and breast cancer. Despite this knowledge, available for a decade, it has never been questioned if the site of chronic inflammation linked to AA creates a milieu that attracts tumor cells to home and grow in the inflamed bones and lungs which are frequent sites of breast cancer metastasis. 相似文献992.
Dr. Wenzel Gruber 《Virchows Archiv : an international journal of pathology》1865,32(1):104-108
Ohne ZusammenfassungHierzu Taf. III. Fig. II. 相似文献
993.
Dr. Wenzel Gruber 《Virchows Archiv : an international journal of pathology》1880,82(3):465-465
Ohne Zusammenfassung 相似文献
994.
995.
Nonvenereal syphilis (endemic syphilis) has existed in Europe since the 16th century. Main characteristics of the disease are its presence for a longer time in a specific territory and its transmission regardless of age and sex, mainly extragenitally in unsanitary living conditions. Nonvenereal syphilis was described under different names in almost all regions of Europe. The primary genital chancre was absent, and lesions were most frequently found in the mouth and affected mostly children. The disease spread in rural areas with poor economic and hygienic conditions. The disease was eradicated in Europe in the 20th century, but it is still present in some rural regions of the Arabian Peninsula, Southwest Asia, and North Africa. 相似文献
996.
997.
998.
999.
Volker JJ Schettler Florian Muellendorff Elke Schettler Christina Platzer Sabine Norkauer Ulrich Julius Claas‐Lennart Neumann 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2019,23(5):467-473
Taking into account the discordance between low‐density lipoprotein cholesterol (LDL‐C) and LDL particle (LDL‐P) number, cardiovascular risk more closely correlates with LDL‐P in patients. The aim of our study was to evaluate the number of lipid particles in patients with severe hypercholesterolemia treated with different lipid‐lowering regimens. Four groups of patients differing with respect to lipid‐lowering therapy were recruited from hypercholesterolemic outpatients and lipoprotein apheresis (LA) facilities, and were treated with statins alone (group A), with statins and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors (PCSK9i) (group B), with statins and LA (group C), or with statins, PCSK9i, and LA (group D). Cholesterol, triglycerides, LDL‐C, high‐density lipoprotein cholesterol (HDL‐C), LDL‐P number and size, HDL‐P number and size were determined using nuclear magnetic resonance spectroscopy. The lowest LDL‐P number was achieved at the end of LA sessions in combination with statins or in combination with statins and a monoclonal PCSK9i (median; 25th and 75th percentile) (group C: 244 nmoL/L: 237, 244, P < 0.05; group D: 244 nmoL/L: 99, 307, P < 0.05). Comparing LDL‐P number at the start of LA (group C: 978 nmoL/L: 728, 1404; group D: 954 nmoL/L: 677, 1521) to the other patient groups (groups A and B), the lowest LDL‐P number was measured in patients treated with PCSK9i and a statin (group B): LDL‐P (762 nmoL/L: 604, 1043, P < 0.05), large LDL‐P (472 nmoL/L: 296, 574, P < 0.05), and small LDL‐P (342 nmoL/L: 152, 494, P < 0.05). Very low‐density lipoprotein and HDL particle sizes remained approximately the same in all groups. LA in combination with statins or in combination with statins and PCSK9i most reduced LDL‐P numbers in hypercholesterolemic patients. 相似文献
1000.